Member Info for Drutor

That would be the dream , can't see it happening when we're around 1p though . I think it's gonna be a big struggle until we get data comming in from phase 1 then we should start to see the price rise and funding comming if data is good

It will be a nice boot of a can I suspect .

" promised Patent application to be confirmed before the end of this year "

If you read the rns is wasn't actually promised .

But are you surprised?

It Is a shame , really good news again and I'd love to top up, but we all know this will put more cost on the company which means another placement. The biggest if is will it be same old raise or has this move away from penny stock actually worked out. I can imagine lots of people on the sideline waiting .

If you want to be crystal.

The Company will be in a position to provide further details of this technical solution once it has filed a patent application, which it anticipates doing by the end of 2024.

When they say anticipates my opinion means they most likely won't.

Like we have said for a long time we could have the best news ever but if the funding isn't there means nothing , I really hope they pull it off and get it sorted and quickly before we slowly rot away. But from the last interview it dosnt sound close .

The only update will be a placement .

Just a little pump and dump

Least we hit the bottom at 1p , now we're free falling

Sad to say but from the interview it sounds like a raise will be needed in-between getting a bigger investment from ii or eles where. I can see this dropping alot more sadly

Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that Prevail Partners, LLC ("Prevail Partners"), an investment fund, has agreed to invest a total of $350,000 (approximately £269,000) in the Company through a subscription for ordinary shares in the Company at a price of US$0.075 per share (approximately 5.6p). This follows a similar investment in the Company by Prevail Partners announced on 18 September 2024. The subscription price represents a premium of approximately 275% to the Company's closing share price on 1 October 2024.

The subscription will take effect in March 2025 ahead of the planned HEMO-CAR-T pediatric study

Probably a stupid question but does the consolidation effect this at all ?

100% brew , he just peddles the same narrative, he wheelie needs to get a different perspective on this company.

There will be no revenue next year let alone this year

Egm *

Anyone know what's going on with agm ?

Would having a exact % make it harder to sell if it varies alot , so maybe they are giving a broader view for when they come to sell this apprant product, or now they know testing in a lab is completely different to real time and nothing works now.

Will finish red 😂

Just as you follow closely shares you are invested in , why wouldn't you follow closely the ones you decide not to , shows your own research is good or bad. Brew gets all this stick but has probably researched more than most of you who post on here. The more nuggets of information he finds he can change his mind , don't mean he has an agenda or is working for a shorting company.

Mr I, how many times have I said stop saying this is the last chance please ! 😂